SYLENTIS
Sylentis is a biotech company founded in 2006 and wholly owned by Pharma Mar S.A. (PHM:SM), with the mission of building a solid and sustainable business and becoming a leader of a new class of medicines based on RNA interference or RNAi. RNAi is a promising approach to silence targets involved in many diseases and represents a new drug mechanism of action. The Sylentis pipeline is aimed at indications with an elevated market potential, including ocular pathologies, inflammatory diseases and ce... ntral nervous system diseases. Given the inherent complications of this technology regarding delivery of the active principle to the target tissue, our strategy is based on first selecting accessible therapeutic targets, which don not require systemic administration of the product. However, the development of formulations for RNAi technology to increase the therapeutic effect of these molecules is an area of great interest to the company
SYLENTIS
Industry:
Biotechnology
Founded:
2006-01-01
Address:
Madrid, Madrid, Spain
Country:
Spain
Website Url:
http://www.sylentis.com
Total Employee:
11+
Status:
Active
Contact:
34 91 804 7667
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Xenova
Xenova publicly quoted biotechnology company focused on the development of novel drugs to treat cancer and addiction.
Current Employees Featured
Official Site Inspections
http://www.sylentis.com Semrush global rank: 9.04 M Semrush visits lastest month: 222
- Host name: ns621.webempresa.eu
- IP address: 178.33.161.178
- Location: Madrid Spain
- Latitude: 40.4143
- Longitude: -3.7016
- Timezone: Europe/Madrid
- Postal: 28008
